The Medicine Maker

Business & Regulation Digital Technologies

Digital Transformation: Veeva la Revolution!

08/01/2022 | Maryam Mahdi | 4 min read

What difference will decentralized trials make to the future of clinical trials?

Business & Regulation Profession

CGT 2022: What’s Next?

07/29/2022 | Angus Stewart | 9 min read

What happened at ISCT 2022’s return to in-person conferencing – and what can a new film release do for advanced therapy?

Business & Regulation COVID-19

Enter the Weird World of Anti-Vaxxers

07/28/2022 | Stephanie Vine | 3 min read

Why, oh why, is there so much nonsense and misinformation about COVID-19 vaccines?

Discovery & Development Drug Discovery

One Small Step for Man, One Giant Leap For Science

07/27/2022 | Stephanie Vine | 8 min read

We speak with Daniel Hornburg from Seer, a biotech company analyzing the proteomes of astronauts.

Discovery & Development Analytical Science

Structure and Data: Connecting the Dots

07/26/2022 | Jamie Stokes | 3 min read

How can an understanding of the relationships between molecular structure and physicochemical data streamline drug discovery and development?

Business & Regulation Profession

In Another Life

07/25/2022 | Stephanie Vine | 4 min read

Members of The Medicine Maker 2022 Power List reveal fascinating facts about themselves.

Business & Regulation Business Practice

Roe v. Wade and the Future of Medical Abortions in the US

07/22/2022 | Maryam Mahdi | 2 min read

How will pharma companies navigate America’s new abortion laws?

Business & Regulation Trends & Forecasts

Post-Conference Reflections

07/21/2022 | Angus Stewart | 9 min read

The International Society for Cell & Gene Therapy convened in person for the first time in two years. We spoke to an attendee for an insight

Business & Regulation Business Practice

Champions of Cell and Gene Therapy

07/20/2022 | Angus Stewart | 7 min read

In our third C+G Champions installment, we ask industry leaders in the cell and gene field about accessibility for the many

Manufacture Vaccines

mRNA IVT: A Modern Balancing Act

07/20/2022 | Jeneffer England | 6 min read

Optimizing mRNA in vitro transcription processes is important – and high-quality kits are a great starting point.

Manufacture Advanced Medicine